March 20, 2023,Zhang Qixiang, deputy secretary of the Harbin Municipal Party Committee and Mayor, Jiang Chuanhai, member of the Standing Committee of the Harbin Municipal Party Committee and deputy mayor, and other 11 leaders visited Beike Biotechnology. Dr. Hu Junyuan, Chairman of Shenzhen Beike Biotechnology Co., Ltd., warmly received the delegation from the Harbin Municipal Government. The two parties conducted in-depth discussions on the implementation of the “Cell Industry Base Project” in Harbin and the realization of the transformation of cell industry results into the integrated development of industry, academia and research in Harbin.
The delegation visited the world’s first fully automatic cell intelligent manufacturing service platform deployed by Beike Biotech. They saw that cell therapy drugs that cure diseases and save lives were automatically executed in the unattended workshop through the “instructions” of the intelligent brain to complete the production of cell products. Through the simulated production control built by the digital twin, the production process, cell status, etc. of the unattended workshop can be intuitively reflected.
Mayor Zhang Qixiang and other delegation members observed the production scene, intensive space, manpower and transparent process of the fully automatic cell intelligent manufacturing system built by Beike Biotech at the site. They expressed the hope that Beike Biotech can bring cutting-edge cell therapy technology and intelligent production solutions to settle in Harbin and promote the development of Harbin’s life and health industry. He also stated that the bioeconomy is a strategic leading industry in Heilongjiang Province’s “14th Five-Year Plan”, and the biomedicine industry is one of the subdivisions of the bioeconomy. As an important area for industrial improvement in Harbin, Harbin has various resource advantages and solid industrial advantages in raw materials, science, education, medical care, etc. in the biopharmaceutical industry, which promotes the development of the city’s biomedicine and health industry. Beike Biotech, as the “leader” in the domestic cell field, is exactly the “ability person” that Harbin urgently needs to develop the biomedical industry. It is hoped that Beike Biotech can inject new momentum into the high-quality development of Harbin’s biomedicine and health industry in this hot land, accelerate the pace, use cell technology to benefit Heilongjiang, and realize the development of good doctors and industrial development for patients.